{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:39:03Z","timestamp":1791567543531,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.phrs.2024.107398","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T17:17:42Z","timestamp":1725470262000},"page":"107398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"208","author":[{"given":"Vali","family":"Musazadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Assadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Faghfouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosra","family":"Soleymani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynab","family":"Kavyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Najafiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2024.107398_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0035-1562942","article-title":"Diagnosis and assessment of NAFLD: definitions and histopathological classification","volume":"35","author":"Burt","year":"2015","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.phrs.2024.107398_bib2","first-page":"11","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"issue":"suppl_1","key":"10.1016\/j.phrs.2024.107398_bib3","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1301\/nr.2007.jun.S57-S63","article-title":"Obesity and nonalcoholic fatty liver disease","volume":"65","author":"Angulo","year":"2007","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.phrs.2024.107398_bib4","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1665-2681(19)31822-8","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease","volume":"8","author":"Almeda-Vald\u00e9s","year":"2009","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2024.107398_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107398_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107398_bib7","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1038\/srep08096","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.phrs.2024.107398_bib8","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/nu15092211","article-title":"Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota","volume":"15","author":"Fusco","year":"2023","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.phrs.2024.107398_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166048","article-title":"Pro-inflammatory cytokines but not endotoxin-related parameters associate with disease severity in patients with NAFLD","volume":"11","author":"du Plessis","year":"2016","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.phrs.2024.107398_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/joim.12508","article-title":"The gut microbiota and metabolic disease: current understanding and future perspectives","volume":"280","author":"Arora","year":"2016","journal-title":"J. Intern. Med."},{"issue":"15","key":"10.1016\/j.phrs.2024.107398_bib11","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107398_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107398_bib13","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/hep.30975","article-title":"Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatol. (Baltim., Md.)"},{"issue":"8","key":"10.1016\/j.phrs.2024.107398_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0737-0806(02)70006-3","article-title":"Probiotics, prebiotics, and synbiotics","volume":"22","author":"Weese","year":"2002","journal-title":"J. Equine Vet. Sci."},{"issue":"13","key":"10.1016\/j.phrs.2024.107398_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/nu16132082","article-title":"Beneficial effects of synbiotics on the gut microbiome in individuals with low fiber intake: secondary analysis of a double-blind, randomized controlled trial","volume":"16","author":"Mantri","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107398_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.105355","article-title":"Synbiotic as an adjunctive agent can be useful in the management of hyperglycemia in adults: An umbrella review and meta-research of meta-analysis studies","volume":"99","author":"Musazadeh","year":"2022","journal-title":"J. Funct. Foods"},{"issue":"7","key":"10.1016\/j.phrs.2024.107398_bib17","first-page":"1222","article-title":"The effects of probiotic\/synbiotic on serum level of zonulin as a biomarker of intestinal permeability: a systematic review and meta-analysis","volume":"49","author":"Ramezani Ahmadi","year":"2020","journal-title":"Iran. J. Public Health"},{"issue":"5","key":"10.1016\/j.phrs.2024.107398_bib18","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s10787-023-01332-8","article-title":"The role of probiotic supplementation in inflammatory biomarkers in adults: an umbrella meta-analysis of randomized controlled trials","volume":"31","author":"Faghfouri","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.phrs.2024.107398_bib19","first-page":"278","article-title":"Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease","volume":"16","author":"Ekhlasi","year":"2017","journal-title":"EXCLI J."},{"issue":"7","key":"10.1016\/j.phrs.2024.107398_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/nu8070397","article-title":"Beneficial effect of synbiotic supplementation on hepatic steatosis and anthropometric parameters, but not on gut permeability in a population with nonalcoholic steatohepatitis","volume":"8","author":"Ferolla","year":"2016","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.phrs.2024.107398_bib21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1017\/S0007114517000204","article-title":"Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial","volume":"117","author":"Mofidi","year":"2017","journal-title":"Br. J. Nutr."},{"issue":"3","key":"10.1016\/j.phrs.2024.107398_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3945\/ajcn.113.068890","article-title":"Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study","volume":"99","author":"Eslamparast","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"issue":"15","key":"10.1016\/j.phrs.2024.107398_bib23","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1080\/10408398.2018.1458021","article-title":"Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of clinical trials: synbiotic supplementation and NAFLD","volume":"59","author":"Hadi","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.phrs.2024.107398_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nutos.2024.05.014","article-title":"Effect of synbiotic supplementation on liver function, metabolic profile and gut microbiota in non-alcoholic fatty liver disease (NAFLD): a meta-analysis of randomized controlled trials","volume":"56","author":"Fadhilah","year":"2024","journal-title":"Clin. Nutr. Open Sci."},{"key":"10.1016\/j.phrs.2024.107398_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.hnm.2023.200194","article-title":"Using synbiotics supplementation to treat hepatic steatosis: a comprehensive meta-analysis of randomized controlled trials","volume":"32","author":"Nojaid","year":"2023","journal-title":"Hum. Nutr. Metab."},{"issue":"12","key":"10.1016\/j.phrs.2024.107398_bib26","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1007\/s10620-019-05699-z","article-title":"Efficacy of probiotics and synbiotics in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"64","author":"Liu","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2024.107398_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/MEG.0000000000001371","article-title":"The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis","volume":"31","author":"Khan","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107398_bib28","article-title":"The promising role of probiotics\/prebiotics\/synbiotics in energy metabolism biomarkers in patients with NAFLD: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2022","journal-title":"Front. Public Health"},{"issue":"10","key":"10.1016\/j.phrs.2024.107398_bib29","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/jgh.16256","article-title":"Use of probiotics, prebiotics, and synbiotics in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"38","author":"Rong","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107398_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1024678","article-title":"The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials","volume":"9","author":"Xing","year":"2022","journal-title":"Front. Nutr."},{"issue":"12","key":"10.1016\/j.phrs.2024.107398_bib31","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1007\/s10620-019-05699-z","article-title":"Efficacy of probiotics and synbiotics in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"64","author":"Liu","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2024.107398_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231174299","article-title":"The effect of synbiotics in patients with NAFLD: a systematic review and meta-analysis","volume":"16","author":"Cai","year":"2023","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.phrs.2024.107398_bib33","unstructured":"Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., W.V.. (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4, 2023 (updated August 2023)."},{"key":"10.1016\/j.phrs.2024.107398_bib34","unstructured":"J. Higgins, J. Thomas, J. Chandler, M. Cumpston, T. Li, M. Page, V. Welch, Cochrane Handbook for Systematic Reviews of Interventions version 6.2. Cochrane; 2021. Updated February 2021, Reference Source (2021)."},{"issue":"4","key":"10.1016\/j.phrs.2024.107398_bib35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.phrs.2024.107398_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst. Rev. 10"},{"key":"10.1016\/j.phrs.2024.107398_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2024.107398_bib38","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"7109","key":"10.1016\/j.phrs.2024.107398_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"bmj"},{"key":"10.1016\/j.phrs.2024.107398_bib40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-011-1887-4","article-title":"Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis","volume":"57","author":"Malaguarnera","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2024.107398_bib41","unstructured":"T. Eslamparast, H. Poustchi, F. Zamani, M. Sharafkhah, R. Malekzadeh, A. Hekmatdoost, The effects of dietary synbiotic supplementation on the liver enzymes, inflammatory markers and hepatic fibrosis in patients with nonalcoholic fatty liver disease: a double-blind randomized clinical trial, (2013)."},{"issue":"1","key":"10.1016\/j.phrs.2024.107398_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/1735-1995.193178","article-title":"Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial","volume":"21","author":"Ekhlasi","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.phrs.2024.107398_bib43","doi-asserted-by":"crossref","unstructured":"A. Asgharian, V. Mohammadi, Z. Gholi, A. Esmaillzadeh, A. Feizi, G. Askari, The effect of synbiotic supplementation on body composition and lipid profile in patients with NAFLD: a randomized, double blind, placebo-controlled clinical trial study, (2017).","DOI":"10.5812\/ircmj.42902"},{"issue":"04","key":"10.1016\/j.phrs.2024.107398_bib44","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.46017","article-title":"The effect of probiotic and\/or prebiotic on liver function tests in patients with nonalcoholic fatty liver disease: a double blind randomized clinical trial","volume":"19","author":"Javadi","year":"2017","journal-title":"Iran. Red. Crescent Med J."},{"issue":"8","key":"10.1016\/j.phrs.2024.107398_bib45","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/jn\/nxy088","article-title":"Daily consumption of synbiotic yogurt decreases liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial","volume":"148","author":"Bakhshimoghaddam","year":"2018","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.phrs.2024.107398_bib46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3350\/cmh.2018.0006","article-title":"Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease","volume":"24","author":"Sayari","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107398_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clnesp.2020.06.020","article-title":"The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: a randomized, placebo-controlled, clinical trial","volume":"39","author":"Abhari","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"issue":"6","key":"10.1016\/j.phrs.2024.107398_bib48","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1053\/j.gastro.2020.01.031","article-title":"Synbiotics alter fecal microbiomes, but not liver fat or fibrosis, in a randomized trial of patients with nonalcoholic fatty liver disease","volume":"158","author":"Scorletti","year":"2020","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.phrs.2024.107398_bib49","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.3390\/nu15133039","article-title":"Effect of a probiotic and a synbiotic on body fat mass, body weight and traits of metabolic syndrome in individuals with abdominal overweight: a human, double-blind, randomised, controlled clinical study","volume":"15","author":"Laue","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.phrs.2024.107398_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/2008-7802.178533","article-title":"The effect of symbiotic supplementation on liver enzymes, C-reactive protein and ultrasound findings in patients with non-alcoholic fatty liver disease: a clinical trial","volume":"7","author":"Asgharian","year":"2016","journal-title":"Int. J. Prev. Med."},{"issue":"12","key":"10.1016\/j.phrs.2024.107398_bib51","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/1751-2980.12561","article-title":"Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: a pilot trial","volume":"18","author":"Manzhalii","year":"2017","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.phrs.2024.107398_bib52","article-title":"The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial","author":"Mitrovi\u0107","year":"2024","journal-title":"Rom. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.phrs.2024.107398_bib53","first-page":"82","article-title":"The effect of gerilact on non-alcoholic fatty liver disease","volume":"27","author":"Sadrkabir","year":"2020","journal-title":"J. Kerman Univ. Med. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2024.107398_bib54","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"25_suppl_2","key":"10.1016\/j.phrs.2024.107398_bib55","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.phrs.2024.107398_bib56","first-page":"177","article-title":"Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity, nature reviews","volume":"16","author":"Ross","year":"2020","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.phrs.2024.107398_bib57","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/01.HYP.0000075790.33892.AE","article-title":"Seventh report of the joint national committee on the prevention, detection, evaluation, and treatment of high blood pressure (JNC 7)","volume":"41","author":"Lenfant","year":"2003","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.phrs.2024.107398_bib58","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/apt.15427","article-title":"Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program","volume":"50","author":"Huber","year":"2019","journal-title":"Aliment Pharm. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2024.107398_bib59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/poh2.31","article-title":"Nonalcoholic fatty liver disease (NAFLD) among older adults","volume":"1","author":"Pitisuttithum","year":"2022","journal-title":"Portal Hypertens. Cirrhosis"},{"issue":"1","key":"10.1016\/j.phrs.2024.107398_bib60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/IJPSYM.IJPSYM_504_19","article-title":"Sample Size and its Importance in Research","volume":"42","author":"Andrade","year":"2020","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.phrs.2024.107398_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"12","author":"Fang","year":"2022","journal-title":"Front Cell Infect. Microbiol."},{"issue":"10","key":"10.1016\/j.phrs.2024.107398_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102277","article-title":"Regulation of gut microbiota and metabolic endotoxemia with dietary factors","volume":"11","author":"Fuke","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.phrs.2024.107398_bib63","first-page":"275","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review, internal and emergency medicine","volume":"19","author":"Di Vincenzo","year":"2024"},{"issue":"4","key":"10.1016\/j.phrs.2024.107398_bib64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/biology13040243","article-title":"Intestinal barrier dysfunction and gut microbiota in non-alcoholic fatty liver disease: assessment, mechanisms, and therapeutic considerations","volume":"13","author":"Long","year":"2024","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.phrs.2024.107398_bib65","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2024.107398_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106397","article-title":"Probiotic therapy, a novel and efficient adjuvant approach to improve glycemic status: an umbrella meta-analysis","volume":"183","author":"Zarezadeh","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107398_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116735","article-title":"GPR41 and GPR43: from development to metabolic regulation","volume":"175","author":"Lee","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2024.107398_bib68","first-page":"6632266","article-title":"Modulation of short-chain fatty acids as potential therapy method for type 2 diabetes mellitus","author":"Tang","year":"2021","journal-title":"Can. J. Infect. Dis. Med Microbiol 2021"},{"issue":"Pt 2","key":"10.1016\/j.phrs.2024.107398_bib69","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20041896","article-title":"A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver","volume":"389","author":"Knight","year":"2005","journal-title":"Biochem J."},{"key":"10.1016\/j.phrs.2024.107398_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02010","article-title":"Prebiotic and synbiotic modifications of beta oxidation and lipogenic gene expression after experimental hypercholesterolemia in rat liver","volume":"8","author":"Alves","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.phrs.2024.107398_bib71","doi-asserted-by":"crossref","first-page":"1169624","DOI":"10.3389\/fendo.2023.1169624","article-title":"Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease","volume":"14","author":"Masse","year":"2023","journal-title":"Front Endocrinol. (Lausanne)"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T23:14:31Z","timestamp":1726787671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824003438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":71,"alternative-id":["S1043661824003438"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107398","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107398"}}